Clinical Trial Update: Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 trial evaluating the combination of sitagliptin with insulin on the progression of coronary atherosclerosis in patients with type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 | Phase 4 | Status: UNKNOWN